Rani Therapeutics Holdings, Inc. (RANI) › Shareholders' EquityRani Therapeutics Holdings, Inc. (RANI) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2020: -$113.34M2021: $47.41M2022: $36.85M2023: $12.87M2024: $1.99M2025: $33.01M$33.01M2020Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$33.01M+1557.1%2024$1.99M-84.5%2023$12.87M-65.1%2022$36.85M-22.3%2021$47.41M+141.8%2020-$113.34M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share